Form 13-F position report

BIOLIFE SOLUTIONS INC

Reported by First Trust Capital Management L P

BLFS CUSIP 09062W204 Manager CIK 0001604488

First reported at 1,425,085 shares this quarter.

New
% of reported 13F value 2.67% This manager · Q3 2026
Shares 1,425,085 Quarter-end amount reported
Reported value $55,364,552 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-09-30 55364552

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for BIOLIFE SOLUTIONS INC held by First Trust Capital Management L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 New 1,425,085 +1,425,085 (0.0%) 2.67% $55,364,552 2026-11-06

Who else reported the position

284 managers reported BIOLIFE SOLUTIONS INC for Q3 2026.

Managers reporting BIOLIFE SOLUTIONS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 6,673,770 +298,225 < 0.01% $259,275,964 9 qtrs
Casdin Capital LLC Reduced 4,500,000 -155,000 7.62% $174,825,000 34 qtrs
GLAZER CAPITAL LLC New 4,084,488 +4,084,488 3.4% $158,682,000 1 qtr
VANGUARD CAPITAL MANAGEMENT LLC Added 1,995,461 +31,377 < 0.01% $77,523,660 3 qtrs
The Goldman Sachs Group Inc Added 1,820,797 +1,289,215 < 0.01% $70,737,963 31 qtrs
STATE STREET CORPORATION Reduced 1,652,823 -3,104 < 0.01% $64,212,174 32 qtrs
First Trust Capital Management L P This report New 1,425,085 +1,425,085 2.67% $55,364,552 1 qtr
Balyasny Asset Management LLC New 1,253,029 +1,253,029 0.06% $48,680,177 1 qtr
Invesco Ltd Reduced 1,245,629 -994,794 < 0.01% $48,392,688 25 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 1,136,220 +49,355 < 0.01% $44,149,298 41 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 06, 2026
Filing type
13F-HR
Position type
Equity

Voting authority reported

Sole
1,425,085
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.